Novel physiological function of fructooligosaccharides.
Study Design
- 研究类型
- Review
- 研究人群
- General population
- 干预措施
- Novel physiological function of fructooligosaccharides. Short-chain fructooligosaccharides
- 对照组
- None
- 主要结局
- GI function, mineral absorption, isoflavone bioavailability
- 效应方向
- Positive
- 偏倚风险
- Unclear
Abstract
Two key properties of short chain fructooligosaccharides (sc-FOS) which lead to physiological functions are indigestibility in the small intestine and fermentability in the colon. Sc-FOS is converted into short chain fatty acids (SCFAs) by intestinal bacteria in the colon and absorbed. Through the metabolic pathway, sc-FOS improves gastrointestinal (GI) condition such as relief from constipation, formation of preferable intestinal microflora and intestinal immunomodulation those are known as prebiotics' function. Besides improvement of GI condition, dietary sc-FOS influences on calcium and magnesium absorption in the colon. A major mineral absorption site is the small intestine, but the colon also works as a Ca and Mg absorption site with an aid of SCFAs made from sc-FOS. Furthermore dietary sc-FOS influences on bioavailability of soy-isoflavones. Plasma and urinal concentration of Genistein and Daidzein, aglycones of Daidzin and Genistin, are higher in the rat fed with sc-FOS than the control rat. An additive effect of dietary isoflavone and sc-FOS was observed on the bone mineral density in OVX mice and moreover sc-FOS increased ceacal beta-glycosidase activity and equol production. These results suggest that FOS increase the bioavailability of isoflavones.
简要概述
Through the metabolic pathway, sc‐FOS improves gastrointestinal condition such as relief from constipation, formation of preferable intestinal microflora and intestinal immunomodulation those are known as prebiotics' function.
Used In Evidence Reviews
Similar Papers
Journal of the Academy of Nutrition and Dietetics · 2017
Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and Soluble Fiber.
Journal of physiology and biochemistry · 2009
Dietary fructooligosaccharides and potential benefits on health.
The American journal of clinical nutrition · 2000
Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome.
Neurogastroenterology and motility · 2017
Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study.
The British journal of nutrition · 2003
Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial.
Journal of the American Medical Directors Association · 2007